The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Current understanding of Alzheimer’s disease diagnosis and treatment
Open accessAbstract
Alzheimer’s disease is the most common cause of dementia worldwide, with the prevalence continuing to grow in part because of the aging world population. This neurodegenerative disease process is characterized classically by two hallmark pathologies: β-amyloid plaque deposition and neurofibrillary tangles of hyperphosphorylated tau. Diagnosis is based upon clinical presentation fulfilling several criteria as well as fluid and imaging biomarkers. Treatment is currently targeted toward symptomatic therapy, although trials are underway that aim to reduce the production and overall burden of pathology within the brain. Here, we discuss recent advances in our understanding of the clinical evaluation and treatment of Alzheimer’s disease, with updates regarding clinical trials still in progress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, both PET imaging and CSF analysis exhibit similar accuracy, and suggest that the optimum test for the diagnosis will depend upon patient/provider preference, cost and availability of facilities [37].”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [37]
In the citing paper
“Current therapeutics to ameliorate and control the cognitive and behavioral symptoms by targeting the NMDA receptor prevent Ca2+ induced excitotoxicity [2, 9–11], and memantine was approved for this purpose in 2003.”
From Current therapeutics for Alzheimer’s disease and clinical trials (2024) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152
Diagnostic and Statistical Manual of Mental Disorders
Siegel, L. J., & Fletcher‐Janzen, E. (2008) · Wiley eBooks · doi:10.1002/9780470373699.speced0655 · Cited by 8,467
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Mechanisms of Gamma Oscillations
Buzsáki, G., & Wang, X.-J. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150444 · Cited by 2,796
Albert, M., DeKosky, S. T., Dickson, D. W., Dubois, B., Feldman, H., Fox, N. C., Gamst, A. C., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2013) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.11.1.96 · Cited by 2,643
Olsson, B., Lautner, R., Andreasson, U., Öhrfelt, A., Portelius, E., Bjerke, M., Hölttä, M., Rosén, C., Olsson, C., Strobel, G., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00070-3 · Cited by 2,049
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Salloway, S., Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304839 · Cited by 1,960
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Doody, R. S., Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312889 · Cited by 1,668
Cited by
Sorted by citations
Items 301–400 of 1,000
Guo, Z., Tian, C., Shi, Y., Song, X., Yin, W., Tao, Q., Liu, J., Peng, G.-P., Wu, Z., Wang, Y., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01727-w · Cited by 23
Liang, Z., Gong, X., Zhao, Y., Zhao, Y., Yu, J., Huang, T., Yang, C., Wu, L., Huang, M., Wang, X., et al. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300669 · Cited by 22
Choi, G.-Y., Lee, I.-S., Moon, E., Choi, H., Je, A. R., Park, J.-H., & Kweon, H. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117000 · Cited by 23
Current Status and Challenges of Stem Cell Treatment for Alzheimer’s Disease
Pacheco‐Herrero, M., Soto-Rojas, L. O., Reyes-Sabater, H., Garcés‐Ramírez, L., de la Cruz‐López, F., Villanueva‐Fierro, I., & Luna‐Muñoz, J. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200863 · Cited by 23
Machine learning models identify predictive features of patient mortality across dementia types
Zhang, J., Song, L., Miller, Z., Chan, K. C. G., & Huang, K.-L. (2024) · Communications Medicine · doi:10.1038/s43856-024-00437-7 · Cited by 20
Zhang, L., Li, D., Yi, P., Shi, J., Guo, M., Yin, Q., Liu, D., Zhuang, P., & Zhang, Y. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.03.018 · Cited by 24
Yu, L., Li, H., Liu, W., Zhang, L., Tian, Q., Li, H., & Li, M. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1548 · Cited by 20
RetractedEffects of Low-Intensity Transcranial Pulsed Ultrasound Treatment in a Model of Alzheimer's Disease
Tramontin, N. D. S., Silveira, P. C. L., Tietbohl, L. T. W., Pereira, B. D. C., Simon, K. R., & Muller, A. P. (2021) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2021.05.007 · Cited by 20
Correia, B., Fernandes, J., Botica, M. J., Ferreira, C., & Quintas, A. (2022) · Medicines · doi:10.3390/medicines9030019 · Cited by 23
Liu, Z.-T., Ma, Y.-T., Pan, S.-T., Xie, K., Shen, W., Lin, S.-Y., Gao, J.-Y., Li, W., Li, G.-Y., Wang, Q., et al. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105309 · Cited by 20
Yang, J. J. (2022) · Acta Neurologica Belgica · doi:10.1007/s13760-022-01907-2 · Cited by 21
MiR‐483‐3p improves learning and memory abilities via XPO1 in Alzheimer's disease
Luo, G., Wang, X., & Liu, C. (2022) · Brain and Behavior · doi:10.1002/brb3.2680 · Cited by 20
Progress in Polymeric Micelles as Viable Wagons for Brain Targeting
Parashar, P., Kanoujia, J., & Kishore, A. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612829666221223101753 · Cited by 20
Changes of tRNA-Derived Fragments by Alzheimer’s Disease in Cerebrospinal Fluid and Blood Serum
Wu, W., Shen, A., Lee, I., Miranda-Morales, E. G., Spratt, H. M., Pappolla, M. A., Fang, X., & Bao, X. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230412 · Cited by 20
Xu, J., Gou, S., Huang, X., Zhang, J., Zhou, X., Gong, X., Xiong, J., Chi, H., & Yang, G. (2023) · Current Alzheimer Research · doi:10.2174/0115672050280894231214063023 · Cited by 21
Zhang, M., Niu, H., Li, Q., Jiao, L., Li, H., & Wu, W. (2023) · Pharmaceuticals · doi:10.3390/ph17010038 · Cited by 20
Lee, S., Jang, K., Lee, H., Jo, Y. S., Kwon, D., Park, G., Bae, S., Kwon, Y. W., Jang, J., Oh, Y., et al. (2024) · Aging Cell · doi:10.1111/acel.14137 · Cited by 21
The Genetics of Alzheimer’s Disease in the Chinese Population
Gan, C., Zhang, T., & Lee, T. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072381 · Cited by 21
Mitra, S., Khatri, S. N., Maulik, M., Bult-Ito, A., & Schulte, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144918 · Cited by 21
The war against Alzheimer, the mitochondrion strikes back!
Zambrano, K., Barba, D., Castillo, K., Robayo, P., Argueta-Zamora, D., Sanon, S., Arizaga, E., Caicedo, A., & Gavilanes, A. W. D. (2022) · Mitochondrion · doi:10.1016/j.mito.2022.03.003 · Cited by 20
Pathogenesis, Animal Models, and Drug Discovery of Alzheimer’s Disease
Xia, Z.-D., Ma, R.-X., Wen, J.-F., Zhai, Y.-F., Wang, Y.-Q., Wang, F.-Y., Liu, D., Zhao, X.-L., Sun, B., Jia, P., et al. (2023) · Journal of Alzheimer's Disease · doi:10.3233/jad-230326 · Cited by 19
Li, Y., Jiang, J. H., Tang, Q., Tian, H., Wang, S., Wang, Z., Liu, H., Yang, J., & Ren, J. (2020) · Neural Plasticity · doi:10.1155/2020/8867547 · Cited by 20
Liu, Z., Proctor, L., Collier, P. N., & Zhao, X. (2021) · IEEE International Conference on Signal and Image Processing Applications (ICSIPA) · doi:10.1109/icsipa52582.2021.9576784 · Cited by 19
Nabizadeh, F., Pourhamzeh, M., Khani, S., Rezaei, A., Ranjbaran, F., Deravi, N., & ADNI (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00908-7 · Cited by 19
Personalized Management and Treatment of Alzheimer’s Disease
Cacabelos, R., Naidoo, V., Martínez-Iglesias, O. A., Corzo, L., Cacabelos, N., Pego, R., & Carril, J. C. (2022) · Life · doi:10.3390/life12030460 · Cited by 19
Chu, X., Wu, P., Yan, H., Chen, X., Fan, L., Wu, Z., Tao, C., Ma, Y., Fu, Y., Guo, Y., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.919143 · Cited by 19
Virtual Screening-Based Drug Development for the Treatment of Nervous System Diseases
Li, Q., Ma, Z.-B., Qin, S., & Zhao, W. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220830105350 · Cited by 19
Insect Models in Nutrition Research
Tonk, M., Vilcinskas, A., & Wagner, A. E. (2022) · Biomolecules · doi:10.3390/biom12111668 · Cited by 19
Sundar, G. N., Narmadha, D., Ramasamy, M. D., Muthusamy, S., Mishra, O. P., Pugalendhi, G. K., Sundararajan, S. C. M., & Ashokkumar, R. (2023) · Soft Computing · doi:10.1007/s00500-023-08390-8 · Cited by 19
Getting ahead of Alzheimer’s disease: early intervention with focused ultrasound
Noel, R. L., Gorman, S. L., Batts, A. J., & Konofagou, E. E. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1229683 · Cited by 20
Wu, J., Zhang, L., Liu, D., Xia, J., Yang, Y., Tang, F., Chen, L., Ao, H., & Peng, C. Y. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116955 · Cited by 21
Zhang, L., Liao, J.-X., Liu, Y.-Y., Luo, H.-L., & Zhang, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1280186 · Cited by 21
Păunescu, H., Dima, L., Ghiţă, I., Coman, L., Ifteni, P. I., Fulga, I., & Coman, O. A. (2020) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001120 · Cited by 19
Xu, C., Garcia, D., Lu, Y., Ozuna, K., Adjeroh, D. A., Wang, K., & Initiative, O. B. O. T. A. D. N. (2021) · Cells · doi:10.3390/cells11010029 · Cited by 19
Wang, X., Yang, Y., Zou, J., Li, Y., & Zhang, X. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.04.124 · Cited by 19
Neuronal KCNQ2/3 channels are recruited to lipid raft microdomains by palmitoylation of BACE1
Dai, G. (2022) · The Journal of General Physiology · doi:10.1085/jgp.202112888 · Cited by 20
Cabreza, J. N., Solano, G. A., Ojeda, S. A. A., & Munar, V. (2022) · International Conference on Artificial Intelligence in Information and Communication (ICAIIC) · doi:10.1109/icaiic54071.2022.9722678 · Cited by 18
Cell Reprogramming for Regeneration and Repair of the Nervous System
Clark, I. H., Roman, A., Fellows, E., Radha, S., Var, S. R., Roushdy, Z., Borer, S. M., Johnson, S., Chen, O. M., Borgida, J. S. W., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10102598 · Cited by 20
Update on Nonhuman Primate Models of Brain Disease and Related Research Tools
Qiao, N., Ma, L., Zhang, Y., & Wang, L. (2023) · Biomedicines · doi:10.3390/biomedicines11092516 · Cited by 18
Etiology, pathogenesis of Alzheimer's disease and amyloid beta hypothesis
Kamble, S. M., Patil, K. R., & Upaganlawar, A. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13205-6.00022-4 · Cited by 18
Singhaarachchi, P. H., Antal, P., Calon, F., Culmsee, C., Delpech, J.-C., Feldotto, M., Geertsema, J., Hoeksema, E. E., Kőrösi, A., Layé, S., et al. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105724 · Cited by 20
Sheikh, M., & Ammar, M. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1398952 · Cited by 23
Puranik, N., Arukha, A. P., Yadav, S. K., Yadav, D., & Jin, J. O. (2021) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x16666210810103838 · Cited by 17
Nanomaterials in Alzheimer’s disease treatment: a comprehensive review
Faiyaz, M., Ganayee, M. A., Akhtar, S., Krishnan, S., Flora, B., Dogra, D., Jha, N. K., Chellappan, D. K., Negi, P., Dua, K., et al. (2021) · Frontiers in Bioscience-Landmark · doi:10.52586/4992 · Cited by 19
Ibuprofen Favors Binding of Amyloid-β Peptide to Its Depot, Serum Albumin
Андреевна, Л. Е., Kazakov, A. S., Deryusheva, E. I., Леонидовна, Н. Е., Shevelyova, M. P., Валериевич, М. А., Nazipova, A. A., Permyakova, M. E., Uversky, V. N., & Permyakov, S. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116168 · Cited by 19
Luteinizing hormone and the aging brain
(2021) · Vitamins and Hormones · doi:10.1016/bs.vh.2020.12.005 · Cited by 17
An Association of Pathogens and Biofilms with Alzheimer’s Disease
Chakravarthi, S. T., & Joshi, S. G. (2021) · Microorganisms · doi:10.3390/microorganisms10010056 · Cited by 18
Mitochondria‐Associated Membranes: A Key Point of Neurodegenerative Diseases
Zhang, Y., Rao, X., Wang, J., Liu, H., Wang, Q., Wang, X., Hua, F., Guan, X., & Lin, Y. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70378 · Cited by 17
Machine learning in expert systems for disease diagnostics in human healthcare
Yadav, A. K., Shukla, R., & Singh, T. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821777-1.00022-7 · Cited by 18
Unsupervised machine learning to identify separable clinical Alzheimer’s disease sub-populations
Prakash, J., Wang, V., Quinn, R. E., & Mitchell, C. S. (2021) · Brain Sciences · doi:10.3390/brainsci11080977 · Cited by 17
Zhai, S., Kim, B., Li, J., Wi, D., Chey, S., Li, G., Rungruangkonkit, S., & Belza, B. L. (2022) · Journal of Gerontological Nursing · doi:10.3928/00989134-20220506-03 · Cited by 18
Singla, R. K., Dhonchak, K., Sodhi, R. K., Babu, M. A., Madan, J., Madaan, R., Kumar, S., Sharma, R., & Shen, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.994018 · Cited by 18
Stem cells in the treatment of Alzheimer's disease – Promises and pitfalls
Bhatti, J. S., Khullar, N., Mishra, J., Kaur, S., Sehrawat, A., Sharma, E., Bhatti, G. K., Selman, A., & Reddy, P. H. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166712 · Cited by 19
Nowak, I., Madej, M., Secemska, J., Sarna, R., & Strzałka‐Mrozik, B. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071931 · Cited by 18
Махаева, Г. Ф., Ковалева, Н. В., Рудакова, Е. В., Boltneva, N. P., Lushchekina, S. V., Astakhova, T. Y., Timokhina, E. N., Serkov, I. V., Proshin, A. N., Soldatova, Y. V., et al. (2024) · Molecules · doi:10.3390/molecules29020321 · Cited by 16
Wang, R., Kang, S., Zhao, Z., Jin, L., Cui, X., Chen, L., Schachner, M., Li, S., Guo, Y., & Zhao, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063408 · Cited by 18
Heydari, R., Khosravifar, M., Abiri, S., Dashtbin, S., Alvandi, A., Nedaei, S. E., Salimi, Z., Zarei, F., & Abiri, R. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115277 · Cited by 19
“Advances in biomarker discovery and diagnostics for alzheimer’s disease”
Bhatia, V., Chandel, A., Minhas, Y., & Kushawaha, S. K. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08023-y · Cited by 20
Vollhardt, A., Frölich, L., Stockbauer, A., Danek, A., Schmitz, C., & Wahl, A.-S. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106845 · Cited by 18
Mulumba, J., Duan, R., Luo, B., Wu, J., Sulaiman, M., Wang, F., & Yang, Y. (2025) · Exploration of neuroscience · doi:10.37349/en.2025.100675 · Cited by 23
Extracellular Vesicles in Psychiatry Research in the Context of RDoC Criteria
Ilgın, C., & Topuzoǧlu, A. (2018) · Psychiatry Investigation · doi:10.30773/pi.2018.09.17 · Cited by 17
Shi, Y., Gu, L., Wáng, Q., Gao, L., Zhu, J., Lu, X., Zhou, F., Zhu, D., Zhang, H., Xie, C., et al. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz005 · Cited by 17
Serum amyloid P secreted by bone marrow adipocytes drives skeletal amyloidosis
Kumar, S., Song, K., Wang, J., Baghel, M. S., Zeng, Y., Shen, K., Zheng, J., Crane, J., Demehri, S., Gao, P., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00924-z · Cited by 16
Al-Dekah, A. M., & Sweileh, W. M. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-101169 · Cited by 19
Human Glucose Transporters in Health and Selected Neurodegenerative Diseases
Szablewski, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157392 · Cited by 18
Dymek, A., Widelski, J., Wojtanowski, K. K., Płoszaj, P., Zhuravchak, R., & Mroczek, T. (2021) · Molecules · doi:10.3390/molecules26061626 · Cited by 16
Donepezil improves vascular function in a mouse model of Alzheimer’s disease
Pellegrini, C., D’Antongiovanni, V., Fornai, M., Duranti, E., Baldacci, F., Bernardini, N., Taddei, S., Virdis, A., Blandizzi, C., Masi, S., et al. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.871 · Cited by 16
Is liquid biopsy mature enough for the diagnosis of Alzheimer’s disease?
Gong, X., Zhang, H., Liu, X., Liu, Y., Liu, J., Fapohunda, F. O., Lü, P., Wang, K., & Tang, M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.977999 · Cited by 17
Bhachawat, S., Shriram, E., Srinivasan, K., & Hu, Y. (2023) · Diagnostics · doi:10.3390/diagnostics13020288 · Cited by 16
Effects of Qi-Fu-Yin on aging of APP/PS1 transgenic mice by regulating the intestinal microbiome
Xiao, Q., Ye, T., Wang, X., Qi, D., & Cheng, X. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1048513 · Cited by 17
Moradi, M., & Demirel, H. (2023) · Signal Image and Video Processing · doi:10.1007/s11760-023-02878-4 · Cited by 16
β-Amyloid peptide modulates peripheral immune responses and neuroinflammation in rats
Adhikary, K., Mohanty, S., Bandyopadhyay, B., Maiti, R., Bhattacharya, K., & Karak, P. (2024) · BioMolecular Concepts · doi:10.1515/bmc-2022-0042 · Cited by 16
Liu, M., Xing, F., Bian, C., Zhao, Y., Zhao, J., Liu, Y., & Zhang, J. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.05.006 · Cited by 16
Carbon Nanostructure-Based Materials: A Novel Tool for Detection of Alzheimer’s Disease
Ashfaq, M., Talreja, N., Chuahan, D., & Srituravanich, W. (2019) · Springer eBooks · doi:10.1007/978-981-13-9636-6_4 · Cited by 16
Konecny, J., Misiachna, A., Hrabinová, M., Pulkrabkova, L., Benková, M., Prchal, L., Kucera, T., Kobrlová, T., Finger, V., Kolcheva, M., et al. (2020) · Biomolecules · doi:10.3390/biom11010003 · Cited by 16
Liu, J., Hou, Z., Wu, J., Liu, K., Li, D., Gao, T., Liu, W., An, B., Sun, Y., Mo, F., et al. (2021) · Cell Proliferation · doi:10.1111/cpr.13085 · Cited by 18
The Diagnostic Pathway From Cognitive Impairment to Dementia in Japan
Black, C. M., Ambegaonkar, B. M., Pike, J., Jones, E., Husbands, J., & Khandker, R. K. (2019) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000322 · Cited by 16
Liu, Y., Xu, S., Bian, H., Qian, Y., Li, H., Shu, S., Chen, J., Cao, X., Gu, Y., Jin, J., et al. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.05.002 · Cited by 16
Jia, J., Sheng, Z., Zhang, Y., Guo, L., Chen, Z.-L., Zhu, D., Zeng, X., & Liu, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-01636-5 · Cited by 17
AlzheimerRAG: Multimodal Retrieval-Augmented Generation for Clinical Use Cases
Lahiri, A. K., & Hu, Q. (2025) · Machine Learning and Knowledge Extraction · doi:10.3390/make7030089 · Cited by 26
Cardiometabolic Modification of Amyloid Beta in Alzheimer’s Disease Pathology
Hefner, M., Baliga, V., Amphay, K., Ramos, D., & Hegde, V. K. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.721858 · Cited by 18
Phuna, Z. X., Panda, B. P., Shivashekaregowda, N. K. H., & Madhavan, P. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102921 · Cited by 16
Non-Invasive Nasal Discharge Fluid and Other Body Fluid Biomarkers in Alzheimer’s Disease
Jung, D. H., Son, G., Kwon, O.-H., Chang, K., & Moon, C. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081532 · Cited by 14
Zhou, S., Liu, L., Zhang, Y., Zhang, Z., Li, H., Fan, F., He, J., Kang, J., & Zuo, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1104954 · Cited by 18
Zhao, R., Wang, P., Liu, L., Zhang, F., Hu, P., Wen, J., Li, H., & Biswal, B. B. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1236221 · Cited by 15
Sanadgol, N., Amini, J., Beyer, C., & Zendedel, A. (2023) · Biomolecules · doi:10.3390/biom13091401 · Cited by 15
Multifunctional Inhibitors of Cholinesterases for the Therapy of Alzheimer’s Disease (A Review)
Махаева, Г. Ф., & Бачурин, С. О. (2023) · Russian Journal of General Chemistry · doi:10.1134/s1070363223150161 · Cited by 15
Zhang, L. (2025) · Organogenesis · doi:10.1080/15476278.2025.2489673 · Cited by 15
Nuzziello, N., Ciaccia, L., & Liguori, M. (2019) · Cells · doi:10.3390/cells9010075 · Cited by 15
Chotipanich, C., Monchaya, N., Kunawudhi, A., Promteangtrong, C., Boonkawin, N., & Jantarato, A. (2020) · Molecular Imaging · doi:10.1177/1536012120947582 · Cited by 15
Wang, K., Xu, C. D., Smith, A., Xiao, D., Navia, R. O., Lu, Y., Xie, C., & Piamjariyakul, U. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110393 · Cited by 15
Schwarck, S., Busse, N., Ziegler, G., Glanz, W., Becke, A., & Düzel, E. (2021) · Frontiers in Sports and Active Living · doi:10.3389/fspor.2021.684089 · Cited by 14
(2021) · Biointerface Research in Applied Chemistry · doi:10.33263/briac123.28002812 · Cited by 15
The role and therapeutic implication of protein tyrosine phosphatases in Alzheimer’s disease
Zhao, X., Li, X., She, L., Li, L., Huang, P. C., & Liang, G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113188 · Cited by 15
Synaptic Organizers in Alzheimer’s Disease: A Classification Based on Amyloid-β Sensitivity
Lee, A. K., Khaled, H., Chofflet, N., & Takahashi, H. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00281 · Cited by 14
Vásquez-Carrasco, E., Hernández-Martínez, J., Sepúlveda-Ramírez, M., Carmine, F., Sandoval, C., Nobari, H., & Valdés-Badilla, P. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102785 · Cited by 15
Will Sirtuin 2 Be a Promising Target for Neuroinflammatory Disorders?
Zhang, F., & Li, B. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.915587 · Cited by 14
Anti-Inflammatory Potency of Mangosteen (Garcinia mangostana L.): A Systematic Review
Setiawan, A. A., Budiman, J., & Prasetyo, A. (2023) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2023.8746 · Cited by 18
Zhou, G., Tang, J., Ma, Y., Fu, X., Liu, J., Yang, R.-Z., Zhang, H., Cai, X., Wang, J., Xie, X., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2220148120 · Cited by 14
m6A methylation in cellular senescence of age-associated diseases
Gao, P., Yao, F., Pang, J., Yin, K., & Zhu, X. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023107 · Cited by 15
Metadata
- Authors
- Weller, J., & Budson, A.
- Affiliations
- Boston University (US)
- Corresponding author
- Weller, Jason
- Venue
- F1000Research
- Publisher
- F1000 Research Ltd
- Published
- 2018-07-31
- Volume
- 7
- Pages
- 1161
- ISSN
- 2046-1402 (ISSN-L)
- PMC
- PMC6073093
- OpenAlex
- W2885706121
- Cited by
- 1,083
- References
- 53
- Citations by year
- 2026: 67 · 2025: 155 · 2024: 147 · 2023: 176 · 2022: 221 · 2021: 194 · 2020: 92 · 2019: 29 · 2018: 2
- FWCI
- 12.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- F1000Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institute on Aging (P30AG013846)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- Alzheimer's disease, dementia, amyloid plaques, tau hyperphosphorylation, neurofibrillary tangles, biomarkers, diagnosis, symptomatic treatment, disease-modifying therapy, clinical trials, neurodegeneration
- MeSH terms
- Alzheimer Disease, Humans, Nerve Net, Amyloid beta-Peptides, tau Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
